Medicare Enrolled

Dr. Harvey Organek, MD

Pulmonary Disease · Farmington Hills, MI
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
29275 W 10 MILE RD, Farmington Hills, MI 48336
2483502722
In practice since 2005 (20 years)
NPI: 1881675833 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Organek from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Organek? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Organek

Dr. Harvey Organek is a pulmonary disease specialist in Farmington Hills, MI, with 20 years of NPI registration. Based on federal Medicare data, Dr. Organek performed 362 Medicare services across 319 unique beneficiaries.

Between the years covered by Open Payments, Dr. Organek received a total of $8,604 from 48 pharmaceutical and/or device companies across 477 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Organek is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ 362 Medicare services $8,604 industry payments

Medicare Practice Summary

Medicare Utilization ↗
362
Medicare services
Bottom 33% in MI for pulmonary disease
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
319
Unique beneficiaries
$303
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~18 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Sleep study with continuous airway pressure, age 6+
A sleep study conducted in a sleep lab that monitors breathing and other body functions while administering continuous airway pressure. This test is performed on patients aged 6 years or older.
120 $504 $1,200
Sleep study in sleep lab (age 6+)
An overnight test conducted in a sleep laboratory to monitor sleep patterns and bodily functions in patients aged 6 years or older.
71 $471 $1,000
Sleep study with heart rate and breathing monitoring
A sleep study that monitors heart rate, breathing, airflow, and physical effort during sleep.
68 $70 $300
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
49 $134 $225
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
37 $90 $175
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
17 $60 $118
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$8,604
Total received (2018-2024)
Avg $1,229/year across 7 years
Top 16% in MI for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
48
Companies
477
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,604 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,454
2023
$1,566
2022
$1,349
2021
$1,036
2020
$1,060
2019
$1,131
2018
$1,008

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Inspire Medical Systems, Inc.
$249
AstraZeneca Pharmaceuticals LP
$174
Mallinckrodt Hospital Products Inc.
$173
Avadel CNS Pharmaceuticals, LLC
$143
Regeneron Healthcare Solutions, Inc.
$101
HARMONY BIOSCIENCES LLC
$82
United Therapeutics Corporation
$66
JAZZ PHARMACEUTICALS INC.
$62
Merck Sharp & Dohme LLC
$53
GlaxoSmithKline, LLC.
$48
Gilead Sciences, Inc.
$42
Baxter Healthcare
$38
Boehringer Ingelheim Pharmaceuticals, Inc.
$35
GENZYME CORPORATION
$32
Harmony Biosciences Llc
$25
CSL Behring
$23
ANI Pharmaceuticals, Inc.
$21
Takeda Pharmaceuticals U.S.A., Inc.
$21
Amgen Inc.
$18
Bayer Healthcare Pharmaceuticals Inc.
$17
3B Medical, Inc.
$16
Philips North America LLC
$14
Top 3 companies account for 41.0% of 2024 payments
All-time payments by company (2018-2024) ›
Boehringer Ingelheim Pharmaceuticals, Inc.
$792
CSL Behring
$644
GlaxoSmithKline, LLC.
$608
Sunovion Pharmaceuticals Inc.
$557
United Therapeutics Corporation
$526
Regeneron Healthcare Solutions, Inc.
$482
Harmony Biosciences LLC
$449
Mylan Specialty L.P.
$416
AstraZeneca Pharmaceuticals LP
$370
HARMONY BIOSCIENCES LLC
$306
JAZZ PHARMACEUTICALS INC.
$305
GENZYME CORPORATION
$300
Inspire Medical Systems, Inc.
$249
Mallinckrodt Hospital Products Inc.
$224
Philips Electronics North America Corporation
$207
Grifols USA, LLC
$201
Gilead Sciences, Inc.
$169
Avadel CNS Pharmaceuticals, LLC
$165
Baxter Healthcare
$150
Axsome Therapeutics, Inc.
$150
Takeda Pharmaceuticals U.S.A., Inc.
$129
Actelion Pharmaceuticals US, Inc.
$114
Merck Sharp & Dohme LLC
$91
Electromed, Inc.
$91
Jazz Pharmaceuticals Inc.
$84
Mallinckrodt Enterprises LLC
$84
Amgen Inc.
$80
Teva Pharmaceuticals USA, Inc.
$73
Bayer HealthCare Pharmaceuticals Inc.
$58
Inogen, Inc.
$58
Advanced Respiratory, Inc
$53
Insmed, Inc.
$42
Paratek Pharmaceuticals, Inc.
$41
Circassia Pharmaceuticals Inc
$37
Bayer Healthcare Pharmaceuticals Inc.
$33
Pulmonx Corporation
$31
Janssen Pharmaceuticals, Inc
$31
Harmony Biosciences Llc
$25
Mallinckrodt LLC
$25
ADVANCED RESPIRATORY, INC
$24
ANI Pharmaceuticals, Inc.
$21
Resmed Corp
$19
PFIZER INC.
$16
Cumberland Pharmaceuticals, Inc.
$16
3B Medical, Inc.
$16
ARBOR PHARMACEUTICALS, INC.
$15
Philips North America LLC
$14
Ultragenyx Pharmaceutical Inc.
$14
Top 3 companies account for 23.8% of all-time payments
Associated products mentioned in payments ›
(7999) SRC Und · (8874) inCourage · (AK6) Vest Therapy · ACTHAR · AIRCURVE · AIRSUPRA · ANORO · ANORO ELLIPTA · AREXVY · Adempas · Arikayce · BELSOMRA · BEVESPI AEROSPHERE · BREO · BREO ELLIPTA · BREZTRI · BROVANA · CHARTIS CATHETER · CINQAIR · CUVITRU · Crysvita · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · Dymista · ELIQUIS · FASENRA · GLASSIA · Hillrom - Life 2000 Ventilation System · Hillrom - Vest System Model 105 Home Care · Horizant · IMFINZI · INOGEN · INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH · INSPIRE · KEYTRUDA · Kcentra · LONHALA MAGNAIR · LUMRYZ · LUNA · NUCALA · NUZYRA · OFEV · OPSUMIT · ORENITRAM · PURIFIED CORTROPHIN GEL · Perforomist · Prolastin-C Liquid · QVAR · REMODULIN · SMARTVEST · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SUNOSI · Sunosi · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · The Vest System Model 105 Home Care · UPTRAVI · UTIBRON NEOHALER · Utibron · VERQUVO · Veklury · Vibativ · WAKIX · Wakix · XARELTO · XYREM · XYWAV · Xyrem · YUPELRI · Yupelri · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a pulmonary disease specialist in Farmington Hills?
Compare pulmonary diseases in the Farmington Hills area by procedure volume, costs, and industry payment transparency.
Browse pulmonary diseases nearby

Geographic Context

Pulmonary diseases within 10 mi
129
Per 100K population
10.1
County median income
$95,296
Nearest hospital
BEAUMONT HOSPITAL - FARMINGTON HILLS
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Organek is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 16% of MI peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Organek experienced with sleep study with continuous airway pressure, age 6+?
Based on Medicare claims data, Dr. Organek performed 120 sleep study with continuous airway pressure, age 6+ services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Organek receive payments from pharmaceutical companies?
Yes. Dr. Organek received a total of $8,604 from 48 companies across 477 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Organek's costs compare to other pulmonary diseases in Farmington Hills?
Dr. Organek's average Medicare payment per service is $303. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Organek) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →